STUB1 and myelodysplastic syndrome: Therefore, to prove the prognostic effect of previously reported ARCH/CHIP for rapid fibrotic progression in pre-PMF [25] and for leukemic transformation in MDS [26] in the MF cohort, we analyzed an association between these mutations and outcomes (OS and PFS) in patients with prefibrotic, overt PMF, and SMF.